Teva Pharmaceutical Industries Ltd ADR buy Barclays PLC
Start price
09.05.24
/
50%
€15.00
Target price
09.05.25
€18.56
Performance (%)
5.33%
Price
26.07.24
€15.80
Summary
This prediction is currently active. With a performance of 5.33%, the BUY prediction by Barclays_PLC for Teva Pharmaceutical Industries Ltd ADR is trending in the right direction. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | 2.265% | 2.265% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Barclays_PLC for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $17.00 to $20.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.40
05.06.24
05.06.24
€19.34
05.06.25
05.06.25
2.60%
26.07.24
26.07.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€11.45
05.02.24
05.02.24
€15.82
05.02.25
05.02.25
37.99%
26.07.24
26.07.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€11.00
29.01.24
29.01.24
€13.86
29.01.25
29.01.25
43.64%
26.07.24
26.07.24